Jan 22, 2024 4:05pm EST ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
Jan 16, 2024 8:00am EST ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
Jan 08, 2024 4:05pm EST ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
May 24, 2023 9:25am EDT ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 18, 2023 4:01pm EDT ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference